Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Aug 21:ljaf323.
doi: 10.1093/bjd/ljaf323. Online ahead of print.

Immunoregulatory effects of TPM203 peptide-nanoparticle therapy in pemphigus vulgaris

Chuda Rujitharanawong  1   2 , Aimee S Payne  1
Affiliations
Editorial

Immunoregulatory effects of TPM203 peptide-nanoparticle therapy in pemphigus vulgaris

Chuda Rujitharanawong et al. Br J Dermatol. .
No abstract available

PubMed Disclaimer

Comment on

  • Safety, tolerability, pharmacokinetics, and pharmacodynamic effects of desmoglein 3-peptide-coupled tolerizing nanoparticles in pemphigus.
    Didona D, Hudemann C, Garn H, Krzikalla D, Wang SH, Hinterseher J, Volkmann K, Polakova A, Zakrzewicz A, Feldhoff S, Tikkanen R, Digigow R, Pfützner W, Santos A, Zimmer CL, Hahmann M, Harnisch S, Rösch S, Huguenin S, Eming R, Hahn M, Schauer F, Antiga E, Senatore S, Maglie R, Täubel J, Ghoreschi K, Meier K, Solimani F, Sticherling M, Sollfrank L, Günther C, Steinbrink K, Magnolo N, van Schaick E, Asnaghi V, Zollmann FS, Pohlner J, Hummel J, Sandbrink R, de Min C, Fleischer S, Möbs C, Hertl M. Didona D, et al. Br J Dermatol. 2025 Aug 7:ljaf311. doi: 10.1093/bjd/ljaf311. Online ahead of print. Br J Dermatol. 2025. PMID: 40795222

LinkOut - more resources